Gene · 10801
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Septin 9 expression regulates 'don't eat me' signals and identifies an immune-epithelial class of intrahepatic cholangiocarcinoma. | Mol Oncol | 2024 | 39082897 | PubTator, text mining | PubMed |
| A novel dual-target Septin9 methylation assay for improved detection of early-stage colorectal cancer and high-grade intraepithelial neoplasia. | BMC Cancer | 2024 | 39080571 | PubTator, text mining | PubMed |
| Clinical diagnostic value of methylated SEPT9 combined with NLR, PLR and LMR in colorectal cancer. | BMC Gastroenterol | 2024 | 39075402 | PubTator, text mining | PubMed |
| Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer. | BMC Cancer | 2024 | 39068425 | PubTator, text mining | PubMed |
| Innovative Semi-Nested Realtime PCR Assay with Extendable Blocking Probe for Enhanced Analysis of SEPT9 Methylation in Colorectal Cancer. | Biomedicines | 2024 | 39062031 | PubTator, text mining | PubMed |
| Genetic change investigation in DOCK1 gene in an Iranian family with sign and symptoms of temporomandibular joint disorder (TMD). | Clin Oral Investig | 2024 | 39020145 | PubTator, text mining | PubMed |
| Pilot Study by Liquid Biopsy in Gastrointestinal Stromal Tumors: Analysis of PDGFRA D842V Mutation and Hypermethylation of SEPT9 Presence by Digital Droplet PCR. | Int J Mol Sci | 2024 | 38928487 | PubTator, text mining | PubMed |
| MiR-503-5p alleviates peripheral neuropathy-induced neuropathic pain in T2DM mice by regulating SEPT9 to inhibit astrocyte activation. | Sci Rep | 2024 | 38906977 | PubTator, text mining | PubMed |
| Dynamic Changes in Circulating Methylated Markers in Response to Antitumor Therapy of Rectal Cancer. | J Gastrointest Cancer | 2024 | 38829580 | PubTator, text mining | PubMed |
| Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma. | Chin J Cancer Res | 2024 | 38751441 | PubTator, text mining | PubMed |
| Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis. | J Med Life | 2024 | 38737656 | PubTator, text mining | PubMed |
| Binucleated human hepatocytes arise through late cytokinetic regression during endomitosis M phase. | J Cell Biol | 2024 | 38727809 | PubTator, text mining | PubMed |
| The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts. | Life Sci Alliance | 2024 | 38719752 | PubTator, text mining | PubMed |
| Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer. | BMC Med Genomics | 2024 | 38689296 | PubTator, text mining | PubMed |
| BCAT1, IKZF1 and SEPT9: methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas. | Biomarkers | 2024 | 38644767 | PubTator, text mining | PubMed |
| Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases. | Ther Adv Med Oncol | 2024 | 38425989 | PubTator, text mining | PubMed |
| CircSEPT9 promotes breast cancer progression by regulating PTBP3 expression via sponging miR-625-5p. | Thorac Cancer | 2024 | 38409914 | PubTator, text mining | PubMed |
| The signature of cancer methylation markers in maternal plasma: Factors influencing the development and application of cancer liquid biopsy assay. | Gene | 2024 | 38342253 | PubTator, text mining | PubMed |
| Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach. | Cancers (Basel) | 2024 | 38339235 | PubTator, text mining | PubMed |
| Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review. | J Oral Pathol Med | 2024 | 38316046 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10801/papers?page=9